JERSEY CITY, N.J., Oct. 31 /PRNewswire-FirstCall/ -- Knight Capital Group, Inc. (NASDAQ:NITE) today announced the formation of Knight Technical Research to provide clients with market analysis. Ralph J. Acampora, an Institutional Investor-ranked technical analyst and former director of technical research at Prudential Equity Group, will lead a team of three, also from Prudential. "With Knight Technical Research, the company will tie technical analysis with trading for the first time in a series of products for clients," said Thomas M. Joyce, Chairman and Chief Executive Officer, Knight Capital Group. "This analysis is a natural fit into our unbundled offering to clients who already come to us for our market knowledge and assistance in making smart trading decisions. I am pleased that an analyst of Ralph's caliber and experience has chosen to work with Knight to develop new technical research products for the market." Mr. Acampora, 64, joined Knight with Peter J. Martin, 42, Phil N. Choremi, 53, and Peter W. Austin, 25, effective today. Knight Technical Research will study and evaluate price and volume momentum along with sentiment and time cycles. They will also apply these disciplines to the fixed income market as well as to currencies, commodities and foreign markets. The company expects to offer clients access to Knight Technical Research before the end of the year. "Knight's energy and talent attracted me and my team to the company," Mr. Acampora said. "To Knight's expertise in trade execution, we bring an expertise in market analysis - the impact of supply and demand on price. As the buy side looks beyond fundamental research and further embraces technical analysis, Knight can add greater value to its clients." Biographies Ralph J. Acampora, 64, is a well-known and respected technical analyst who brings to Knight years of experience and accomplishments. He joins Knight after 15 years as Prudential Securities' Director of Technical Analysis. He was one of the first technical analysts to foresee that the Dow Jones Industrial Average would achieve record gains. Mr. Acampora was named to the 2005 All-America Research Technical Analysis Third Team in the October 2005 issue of Institutional Investor. He has consistently been ranked in this category for the past decade. Prior to his employment at Prudential, Mr. Acampora worked from 1980 to 1990 at Kidder Peabody & Co. Before that, he was with Smith Barney, Harris, Upham & Co. from 1969 to 1980. His financial career began with Distributor's Group, a mutual fund complex owned by US Life. He went to Iona College in New Rochelle, New York, and graduated from St. Joseph's Seminary in Yonkers, New York. He is a Chartered Market Technician, a designation he helped create and which is now recognized by the Securities and Exchange Commission. Peter J. Martin, 42, served in various capacities at Prudential for the past 11 years, most recently as Vice President, Technical Analysis for Prudential Equity Group, where he provided both the Institutional and Retail sales forces with in-depth analysis of both domestic and international markets, sectors, groups and individual securities. Mr. Martin also provided analysis to portfolio managers and traders, assisted with the development and presentation of weekly commentary, and provided technical opinions to fundamental and quantitative analysts. He earned a bachelor's degree in finance from Monmouth University, West Long Branch, N.J., and is a Chartered Market Technician. Phil N. Choremi, 53, comes to Knight from Prudential Equity Group where, since January 1994, he has worked directly for Ralph Acampora producing retail and institutional research. In October 2004, he was named Senior Technical Analyst and Vice President supporting Listed and Nasdaq Trading. Prior to working at Prudential, Mr. Choremi was a technical analyst at Thomson McKinnon Securities. He earned a bachelor's degree in architecture from the University of Pennsylvania in Philadelphia. Peter W. Austin, 25, was with Prudential Equity Group since February 2004 and covered both the biotechnology industry and the brokerage industry for Prudential Equity Group, assisting Senior Analysts with the launch of several small- and mid-cap biotech names as well as sell-side research coverage of securities firms. He graduated from the University of Maryland with a bachelor's degree in finance and has completed Level I of the Chartered Financial Analyst program. About Knight Knight is a leading provider of comprehensive trade execution and asset management services. Our Equity Markets business offers institutions and broker-dealers high quality trade execution and capital commitment across the depth and breadth of the equity market. Our Asset Management business, Deephaven Capital Management, is a multi-strategy investment manager focused on delivering risk-adjusted returns with low volatility for institutions and high net worth individuals. Knight strives to be a valued partner by providing superior service and continually enhancing its offering to meet client needs. More information about Knight can be obtained at http://www.knight.com/ . Certain statements contained herein constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations, estimates and projections about the Company's industry, management's beliefs and certain assumptions made by management. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Since such statements involve risks and uncertainties, the actual results and performance of the Company may turn out to be materially different from the results expressed or implied by such forward-looking statements. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Unless otherwise required by law, the Company also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made herein; however, readers should carefully review reports or documents the Company files from time to time with the Securities and Exchange Commission including, without limitation, the risks and uncertainties detailed under the headings "Certain Factors Affecting Results of Operations" and "Risks Affecting our Business" in the Company's Annual Report on Form 10-K. DATASOURCE: Knight Capital Group, Inc. CONTACT: Margaret Wyrwas, Senior Managing Director, Corporate Communications & Investor Relations, +1-201-557-6954, , or Kara Fitzsimmons, Vice President, Corporate Communications, +1-201-356-1523, , or Greta Morley, Vice President, Marketing Communications & Public Relations, +1-201-557-6948, , or Molly McDowell, Analyst, Corporate Communications & Investor Relations, +1-201-356-1723, , all of Knight Capital Group, Inc. Web site: http://www.knight.com/

Copyright

Nightstar Therapeutics Plc ADS (NASDAQ:NITE)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Nightstar Therapeutics Plc ADS Charts.
Nightstar Therapeutics Plc ADS (NASDAQ:NITE)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Nightstar Therapeutics Plc ADS Charts.